NORMAN BEISCHER MEDICAL RESEARCH FOUNDATION
Concentration RiskAbout
The Norman Beischer Medical Research Foundation is an Australian philanthropic foundation supporting and promoting improvements in the reproductive health of women and in the health of their babies and infants. It primarily funds clinically based scientific research in obstetrics, gynaecology, and neonatal conditions by leading and emerging researchers, aiming to educate and inform medical practice in Australia and elsewhere.
Giving Philosophy
The Foundation approaches giving by funding highly innovative, clinically-based research projects that show potential for major benefit or for securing larger grants from other funders. It prioritises seed funding and also provides substantial multi-year fellowships to support early-to-mid-career clinician researchers. The Foundation values respect, integrity, diversity, equity, inclusion, dignity, accountability, and transparency, operating with the highest ethical standards.
Tips for Applicants
Applicants should use the official application template available on the foundation's website. For multi-year Innovation Grants, contact the Executive Director prior to applying. Full disclosure of all available and pending funds for research support is required. The Principal Investigator must be located in Victoria, and clinical research is a priority. Ensure all necessary Human Research Ethics Committee (or Animal, if applicable) approvals are secured before grant funds are released. Funds are generally available for research assistants' salaries, consumable items, and equipment, but not for secretarial assistance, personal computers, standard institutional items, or travel expenses. Attach a two-page summary curriculum vitae and declare any real or perceived conflicts of interest.
Programs & Opportunities (6)
Seed funding to support highly innovative research projects in any area of obstetric, gynaecological, or neonatal conditions, showing potential for major benefit or future major grant applications. Max $73,000 for one year, multi-year considered in exceptional circumstances. Principal Investigator must be located in Victoria.
Three-year fellowship ($600k over 3 years) for mid-career obstetrician/gynaecologist researcher. PhD must be less than 7 years old.
Seed funding for highly innovative research projects in obstetrics, gynaecology or neonatal conditions. Must be clinical research with human subjects. PI must be in Victoria.
Funds clinical research positions aimed at advancing the understanding and treatment of conditions affecting women and infants.
Innovation Grants provide seed funding for highly innovative research projects with potential for major benefit or future grant applications. They support clinically based scientific research in obstetrics, gynaecology, and neonatal conditions, open to researchers at any career stage, with the Principal Investigator located in Victoria, Australia.
Innovation Grants provide seed funding for highly innovative research projects with potential for significant benefit or future major grant applications. They support research into obstetric, gynaecological, or neonatal conditions.
Notable Grants
- $600,000 (over 3 years) to Associate Professor Lisa Hui (2022-2024) for the Norman Beischer Clinical Research Fellowship focusing on congenital cytomegalovirus (CMV) prevention.
- $600,000 (over 3 years) to Associate Professor Fiona Brownfoot (2021-2023) for the Norman Beischer Clinical Research Fellowship focusing on preeclampsia.
- $600,000 (over 3 years) to Dr Clare Whitehead (commencing after 2022) for the third Norman Beischer Clinical Research Fellowship.
- Bursaries to La Trobe University for nurses and midwives.
- Six scholarships of $10,000 each per annum to Deakin University to support the training of Indigenous nurses and midwives.
- $70,000 to Dr Anthea Ng for research on maternal microparticle biomarkers for placental complications (2022 Innovation Grant).
- $65,000 to Dr Yana Gavrilov for novel therapies for preterm birth (2022 Innovation Grant).
- $65,000 to Dr Natalie Hannan for targeting mitochondrial dysfunction in preeclampsia (2022 Innovation Grant).
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $515K | $1.8M | $64.2M | $-1,288,869 |
| 2022 | $1.7M | $1.6M | $63.4M | $101K |
| 2021 | $4.4M | $1.2M | $68.2M | $4.3M |
| 2020 | $2.4M | $1.0M | $60.9M | $1.4M |
| 2019 | $4.2M | $966K | $62.1M | $4.1M |
| 2018 | $2.6M | $685K | $55.7M | $2.2M |
| 2017 | $3.1M | $798K | $51.6M | $3.2M |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-26005864282
- ABN
- 26005864282
- Sector
- health
- Website
- nbmrf.org.au
- Financial Year
- 2023
Focus Areas
Board & Leadership (8)
- Anne Beischerdirector
- Bernadette Whitedirector
- DAVID ALLENdirector
- JOHN FASTdirector
- Nicole Longdirector
- Paul Broadfootdirector
- Sandra Fairchilddirector
- Sarah Conrondirector
Financials
- Revenue
- $515K
- Assets
- $64.2M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 18
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 3142
- Locality
- HAWKSBURN
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 10/10
- LGA
- Stonnington
- SA2 Region
- Toorak
- Entities in Area
- 191